Active Ingredient
Oxymetazoline 0.05%
The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Major Nasal Decongestant (NDC 0904-7427). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding, keep out of the reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Oxymetazoline 0.05%
Nasal Decongestant
Symptoms persist
ask a health professional before use.
if swallowed, get medical help or contact a Poison Control Center right away.
Benzalkonium Chloride, Disodium EDTA, Glycerin, Microcrystalline Cellulose and Carboxymethylcellulose Sodium, Polyethylene Glycol 300, Povidone, Propylene Glycol, Purified Water, Sodium Phosphate Dibasic, Sodium Phosphate Monobasic
* Please review the disclaimer below.